Capricor Therapeutics, Inc. (CAPR)
25.94
-0.22
(-0.82%)
USD |
NASDAQ |
Jun 09, 15:50
Capricor Therapeutics SG&A Expense (Quarterly) : 9.396M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| REGENXBIO, Inc. | 21.31M |
| Inovio Pharmaceuticals, Inc. | 7.880M |
| Regeneron Pharmaceuticals, Inc. | 647.70M |
| iBio, Inc. | 5.111M |
| AbbVie, Inc. | 3.578B |